MSD’s HIV treatment is now back on track after an earlier hit which saw the FDA place a clinical hold on the therapy.

This expansion of our Durham plant is a crucial component of the more than $12 billion Merck has invested toward U.S. capital ...

MSD has opened the doors of a $1 billion manufacturing facility at its site in Durham, North Carolina, that will be used to produce the bulk drug substance for its HPV vaccine Gardasil.

Merck & Co. (MSD outside the U.S. and Canada) has just unveiled a brand-new, cutting-edge vaccine manufacturing facility at ...

Merck opens new, $1 billion, 225,000-sq ft facility dedicated to vaccine manufacturing at its Durham, North Carolina, site: Durham, North Carolina Wednesday, March 12, 2025, 09:00 ...

Sichuan Kelun-Biotech Biopharma has become the first drugmaker to usher a TROP2-targeted antibody-drug conjugate to ...

Opening highlights effort to expand U.S. manufacturing through a $1 billion investment Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today the opening of a new ...

(RTTNews) - Merck (MRK), known as MSD outside the U.S., and Canada, Tuesday has inaugurated a new $1 billion, 225,000-square-foot vaccine manufacturing facility at its Durham, North Carolina ...

Kioxia Corporation has been named a Clarivate Top 100 Global Innovators 2025, an award given to the most innovative global companies by Clarivate Plc. This is the fourth time Kioxia has received this ...

Discover how one organization is bridging global medical education standards to ensure quality healthcare in the United States and around the ...